CNBC
US · 1 hrs ago
✦ 72◉ Centre
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
72Accuracy
0Ratings
0Comments
AI Analysis
Accuracy 72/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ⚠ Misleading headline
Hims & Hers' stock fell 16% following the company's first-quarter loss and weak earnings guidance; the company had reached a deal with Novo Nordisk in March to sell GLP-1 weight loss drug Wegovy on its platform.
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!